Morningstar Investment Services’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-40,505
Closed -$707K 371
2024
Q3
$707K Buy
40,505
+910
+2% +$15.9K 0.01% 239
2024
Q2
$644K Sell
39,595
-587
-1% -$9.55K 0.01% 228
2024
Q1
$580K Sell
40,182
-39,395
-50% -$569K 0.01% 219
2023
Q4
$833K Buy
79,577
+40,314
+103% +$422K ﹤0.01% 241
2023
Q3
$401K Buy
39,263
+2,076
+6% +$21.2K 0.01% 224
2023
Q2
$281K Buy
37,187
+2,266
+6% +$17.1K ﹤0.01% 225
2023
Q1
$308K Buy
34,921
+3,140
+10% +$27.7K ﹤0.01% 205
2022
Q4
$311K Sell
31,781
-1,767
-5% -$17.3K ﹤0.01% 196
2022
Q3
$292K Buy
33,548
+1,250
+4% +$10.9K ﹤0.01% 193
2022
Q2
$256K Buy
32,298
+5,667
+21% +$44.9K ﹤0.01% 202
2022
Q1
$245K Buy
26,631
+1,395
+6% +$12.8K ﹤0.01% 218
2021
Q4
$202K Buy
25,236
+1,733
+7% +$13.9K ﹤0.01% 235
2021
Q3
$233K Buy
23,503
+4,040
+21% +$40.1K ﹤0.01% 212
2021
Q2
$195K Buy
19,463
+3,906
+25% +$39.1K ﹤0.01% 214
2021
Q1
$176K Buy
+15,557
New +$176K ﹤0.01% 205
2020
Q4
Sell
-22,413
Closed -$198K 216
2020
Q3
$198K Sell
22,413
-626
-3% -$5.53K ﹤0.01% 198
2020
Q2
$281K Sell
23,039
-1,450
-6% -$17.7K ﹤0.01% 181
2020
Q1
$208K Sell
24,489
-436
-2% -$3.7K ﹤0.01% 194
2019
Q4
$244K Sell
24,925
-4,410
-15% -$43.2K ﹤0.01% 179
2019
Q3
$202K Sell
29,335
-2,926
-9% -$20.1K ﹤0.01% 187
2019
Q2
$298K Buy
32,261
+9,102
+39% +$84.1K ﹤0.01% 189
2019
Q1
$363K Sell
23,159
-2,944
-11% -$46.1K 0.01% 171
2018
Q4
$403K Sell
26,103
-669
-2% -$10.3K 0.01% 164
2018
Q3
$577K Sell
26,772
-1,489
-5% -$32.1K 0.01% 153
2018
Q2
$687K Buy
28,261
+4,177
+17% +$102K 0.01% 146
2018
Q1
$412K Sell
24,084
-325
-1% -$5.56K 0.01% 162
2017
Q4
$463K Buy
24,409
+2,428
+11% +$46.1K 0.01% 160
2017
Q3
$387K Buy
+21,981
New +$387K 0.01% 161
2015
Q1
Sell
-15,363
Closed -$884K 218
2014
Q4
$884K Sell
15,363
-9,035
-37% -$520K 0.04% 159
2014
Q3
$1.31M Sell
24,398
-74,305
-75% -$3.99M 0.07% 142
2014
Q2
$5.17M Sell
98,703
-81,543
-45% -$4.27M 0.3% 84
2014
Q1
$9.52M Buy
180,246
+13,976
+8% +$738K 0.65% 47
2013
Q4
$6.66M Buy
166,270
+31,155
+23% +$1.25M 0.5% 55
2013
Q3
$5.08M Buy
135,115
+57,765
+75% +$2.17M 0.44% 59
2013
Q2
$3.03M Buy
+77,350
New +$3.03M 0.32% 74